Bill > SB504

This bill makes several changes to pharmacy practice laws, including authorizing licensed healthcare professionals to dispense up to a 30-day supply of noncontrolled oral anti-cancer medications under specific conditions, such as having a full-time pharmacist on staff for consultation and adhering to United States Pharmacopeia (USP) standards and other relevant laws. It also modifies requirements for displaying pharmacy licenses and permits, making them readily retrievable rather than conspicuously displayed. The bill expands the ability to engage in remote processing, which is the handling of prescription information from a distance, to include licensed advanced pharmacy technicians. Additionally, it removes the requirement for a pharmacist's name or initials to appear on the label of controlled drugs or prescriptions, revises the definition of the "practice of pharmacy" to encompass a broader scope of patient care services based on a pharmacist's qualifications and setting, and reduces the board of pharmacy's authority over collaborative pharmacy practice agreements, which are formal arrangements where pharmacists and physicians agree on specific patient care functions. Furthermore, the bill eliminates the examination requirement for licensure as an advanced pharmacy technician and prohibits the pharmacy board from testing applicants on pharmacy jurisprudence or law, which refers to the specific laws and regulations governing pharmacy practice.